Wednesday, July 16, 2025
spot_img

Cipla to scale up Remdesivir production 2-fold

Date:

Share post:

spot_imgspot_img

 


NEW DELHI, April 13: Pharmaceutical company Cipla on Tuesday said it has scaled up the production of remdesivir by 2 times from the last wave of the pandemic.

As the demand for the drug surges, the government has prohibited the exports of remdesivir injection and its active pharmaceutical ingredients (API).

“Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network, to service the demand,” the company said in a statement.

“To ensure fair and equitable access, we are working with the regulatory authorities to restrict supply of the drug only to hospital channels and especially those regions with high burden of severe Covid-19,” Cipla said.

On Tocilizumab, the company said that given the spike in cases and surge in demand, it is facing a shortage and working closely with its partner in taking necessary steps to ensure availability of the drug.

“We expect intermittent supplies as the demand outstrips supply with some more receipts at the earliest,” it added.

spot_imgspot_img

Related articles

Raid in city leads to seizure of prohibited plastic items

SHILLONG, July 15: In a joint crackdown on the illegal sale of plastic products, the Meghalaya State Pollution...

Bangladesh plans to demolish Satyajit Ray’s ancestral home

Dhaka, July 15: The ancestral home of legendary filmmaker Satyajit Ray in Dhaka is set for demolition, raising...

POT POURRI

Trump set for rare second state visit to UK LONDON, July 15: Donald Trump will make an unprecedented second...

World Watch

Pak rains kill five more; death toll hits 116 ISLAMABAD, July 15: Pakistan has reported a total of 116...